219 related articles for article (PubMed ID: 33065725)
21. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.
Salgia RJ; Goodrich NP; Simpson H; Merion RM; Sharma P
Dig Dis Sci; 2014 Aug; 59(8):1976-82. PubMed ID: 24557576
[TBL] [Abstract][Full Text] [Related]
22. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
23. Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates.
Hayashi R; Kogiso T; Kikuchi N; Yamamoto K; Nakamura S; Egawa H; Hagiwara N; Tokushige K
PLoS One; 2022; 17(4):e0267125. PubMed ID: 35439259
[TBL] [Abstract][Full Text] [Related]
24. Portopulmonary hypertension.
Cartin-Ceba R; Krowka MJ
Clin Liver Dis; 2014 May; 18(2):421-38. PubMed ID: 24679504
[TBL] [Abstract][Full Text] [Related]
25. Predictors of survival in portopulmonary hypertension: a 20-year experience.
Aggarwal M; Li M; Bhardwaj A; Wallace WD; Wang X; Carey WD; Dweik RA; Heresi GA; Tonelli AR
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):449-456. PubMed ID: 34907982
[TBL] [Abstract][Full Text] [Related]
26. Struggling Between Liver Transplantation and Portopulmonary Hypertension.
Jose A; Jones CR; Elwing JM
Heart Fail Clin; 2023 Jan; 19(1):55-65. PubMed ID: 36435573
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
Raevens S; Geerts A; Devisscher L; Van Vlierberghe H; Van Steenkiste C; Colle I
Acta Gastroenterol Belg; 2021; 84(1):95-99. PubMed ID: 33639700
[TBL] [Abstract][Full Text] [Related]
28. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
Awdish RL; Cajigas HR
Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
[TBL] [Abstract][Full Text] [Related]
29. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Management in Liver Transplantation in the Horizon 2020.
Sendra C; Carballo-Rubio V; Sousa JM
Transplant Proc; 2020 Jun; 52(5):1503-1506. PubMed ID: 32278579
[TBL] [Abstract][Full Text] [Related]
30. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
31. Portopulmonary hypertension: survival and prognostic factors.
Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
[TBL] [Abstract][Full Text] [Related]
32. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.
Hollatz TJ; Musat A; Westphal S; Decker C; D'Alessandro AM; Keevil J; Zhanhai L; Runo JR
Liver Transpl; 2012 Jun; 18(6):686-95. PubMed ID: 22315210
[TBL] [Abstract][Full Text] [Related]
33. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes.
Del Valle KT; Krowka MJ; Heimbach JK; Taner T; DuBrock HM
Transplant Direct; 2022 Dec; 8(12):e1410. PubMed ID: 36398194
[TBL] [Abstract][Full Text] [Related]
34. Portopulmonary hypertension: Results from a 10-year screening algorithm.
Krowka MJ; Swanson KL; Frantz RP; McGoon MD; Wiesner RH
Hepatology; 2006 Dec; 44(6):1502-10. PubMed ID: 17133488
[TBL] [Abstract][Full Text] [Related]
35. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
[TBL] [Abstract][Full Text] [Related]
36. Portopulmonary hypertension and hepatopulmonary syndrome.
Aldenkortt F; Aldenkortt M; Caviezel L; Waeber JL; Weber A; Schiffer E
World J Gastroenterol; 2014 Jul; 20(25):8072-81. PubMed ID: 25009379
[TBL] [Abstract][Full Text] [Related]
37. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
Fussner LA; Krowka MJ
Curr Gastroenterol Rep; 2016 Jun; 18(6):29. PubMed ID: 27098816
[TBL] [Abstract][Full Text] [Related]
38. "Porto-pulmonary hypertension: a comprehensive review".
Liberal R; Grant CR; Baptista R; Macedo G
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):157-67. PubMed ID: 25659878
[TBL] [Abstract][Full Text] [Related]
39. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival.
Fussner LA; Iyer VN; Cartin-Ceba R; Lin G; Watt KD; Krowka MJ
Liver Transpl; 2015 Nov; 21(11):1355-64. PubMed ID: 26077312
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates.
DesJardin JT; Manicardi M; Svetlichnaya Y; Kolaitis NA; Papolos AI; Selby VN; Zier LS; Klein L; Aras MA; Yao FY; Roberts JP; De Marco T
Clin Transplant; 2019 Jul; 33(7):e13585. PubMed ID: 31074522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
